Citation Impact
Citing Papers
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Immune Cells in Hyperprogressive Disease under Immune Checkpoint-Based Immunotherapy
2022
Works of Xin Ba being referenced
Hyperprogressive Disease in Cancers Treated With Immune Checkpoint Inhibitors
2021